About this trial
Arthroscopic knee surgery is one of the most commonly performed procedures in orthopedic surgery. More than 50% of patients experience moderate to severe pain after the operation. Inadequate postoperative pain control and poor recovery quality can negatively impact physiotherapy protocols, prolong hospital stays, and consequently lead to cognitive dysfunction, systemic infections, and increased healthcare costs.
Therefore, reducing postoperative pain and improving recovery quality are of great importance. In our clinic, a variety of analgesic techniques are routinely employed as part of a multimodal analgesia approach for patients undergoing arthroscopic knee surgery. One of these techniques is the simultaneous application of the IPACK block and the adductor canal block.
In this study, we aim to evaluate the effectiveness of these blocks on postoperative recovery quality in patients undergoing arthroscopic knee surgery.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Patients aged between 18 and 50 years,
Scheduled for arthroscopic knee surgery under spinal anesthesia due to knee pathology
Patients classified as ASA physical status I-II-III according to the American Society of Anesthesiologists risk classification
Disqualifiers
Coagulopathy
ASA IV-V patients
Uncooperable patients
Patients who refuses to participate in study
Trial design
Parallel
Treatments tested in this trial
IPACK and adductor canal block with Bupivacaine 0.25%
Procedure/SurgeryiPACK block is infiltration between the Popliteal Artery and the Capsule of the Knee. iPACK and adductor canal blocks are performed with ultrasound guidence under sterile conditions.
Spinal Anesthesia with Bupivacaine
Procedure/SurgerySpinal Anesthesia is a basic anesthesia method used for years to grant anesthesia for surgeries for lower extremities and lower torso surgeries.
Treatment groups
Trial outcomes
Primary outcomes
Quality of Recovery
Quality of Recovery of the patients will be assessed with QoR-15 questionnaire. Its scoring will range between 0 and 150 points.
Secondary outcomes
Analgesic Consumption
The total analgesic consumption of patients according to the patient controlled analgesia device which measures the opioid consumption for 24 hours.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.